Free Trial

Revelation Biosciences (REVB) Short Interest Ratio & Short Volume

Revelation Biosciences logo
$2.57 +0.06 (+2.39%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$2.58 +0.01 (+0.39%)
As of 05/21/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Revelation Biosciences Short Interest Data

Revelation Biosciences (REVB) has a short interest of 69,600 shares, representing 7.22% of the float (the number of shares available for trading by the public). This marks a -41.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 127,779 shares to cover all short positions.

Current Short Interest
69,600 shares
Previous Short Interest
118,500 shares
Change Vs. Previous Month
-41.27%
Dollar Volume Sold Short
$212,280.00
Short Interest Ratio
0.6 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
905,000 shares
Float Size
963,500 shares
Short Percent of Float
7.22%
Today's Trading Volume
50,591 shares
Average Trading Volume
127,779 shares
Today's Volume Vs. Average
40%
Short Selling Revelation Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

REVB Short Interest Over Time

REVB Days to Cover Over Time

REVB Percentage of Float Shorted Over Time

Revelation Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202569,600 shares $212,280.00 -41.3%7.2%0.6 $3.05
4/15/2025118,500 shares $361,425.00 +131.0%13.1%0.8 $3.05
3/31/202551,300 shares $134,919.00 +118.3%5.7%0.3 $2.63
3/15/202523,500 shares $79,900.00 -61.9%2.6%0.1 $3.40
2/28/202561,700 shares $215,333.00 -31.1%6.8%0.3 $3.49
2/15/202589,500 shares $383,060.00 +41.2%17.1%0.4 $4.28
1/31/202563,400 shares $239,018.00 +38.1%12.1%0.3 $3.77
1/15/202545,900 shares $359,856.00 -80.9%0.6%0.2 $7.84
12/31/2024240,400 shares $110,824.40 +450.1%2.9%0.1 $0.46
12/15/202443,700 shares $15,732.00 -65.3%0.5%0 $0.36
11/30/2024125,800 shares $95,608.00 -70.7%2.0%0.1 $0.76
11/15/2024428,600 shares $344,165.80 +937.8%10.0%0.8 $0.80
10/31/202441,300 shares $35,228.90 +81.1%1.1%0 $0.85
10/15/202422,800 shares $17,784.00 -59.7%0.6%0 $0.78
9/30/202456,600 shares $48,211.88 +120.2%1.5%0 $0.85
9/15/202425,700 shares $23,104.33 -78.7%0.7%0 $0.90
8/31/2024120,400 shares $138,460.00 -61.6%7.3%0.1 $1.15
8/15/2024313,700 shares $280,886.98 +645.1%19.1%0.2 $0.90
7/31/202442,100 shares $69,465.00 -10.6%2.6%0.1 $1.65
7/15/202447,100 shares $88,077.00 -44.3%2.9%0.1 $1.87
6/30/202484,500 shares $161,395.00 +128.4%5.2%0.1 $1.91
6/15/202437,000 shares $81,770.00 +68.2%2.3%0.1 $2.21
5/31/202422,000 shares $41,140.00 -11.3%1.4%0.3 $1.87
5/15/202424,800 shares $48,360.00 +40.1%1.5%0.2 $1.95
4/30/202417,700 shares $37,299.21 -4.3%1.1%0.1 $2.11
4/15/202418,500 shares $33,762.50 -43.6%1.1%0 $1.83
3/31/202432,800 shares $89,872.00 No Change8.3%0.1 $2.74
3/15/202432,800 shares $79,048.00 -31.5%8.3%0.1 $2.41
2/29/202447,900 shares $174,835.00 +32.7%12.3%0.1 $3.65
2/15/202436,100 shares $109,022.00 -70.0%9.2%0.1 $3.02
1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80
1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22
12/31/2023451,700 shares $226,166.19 +4.7%7.3%6.7 $0.50
12/15/2023431,400 shares $237,701.40 +1,878.9%7.0%7.2 $0.55
11/30/202321,800 shares $15,763.58 -29.5%0.4%0.4 $0.72
11/15/202330,900 shares $19,476.27 +134.1%0.5%0.6 $0.63
10/31/202313,200 shares $7,933.20 -50.6%0.2%0.2 $0.60
10/15/202326,700 shares $18,206.73 +69.0%0.4%0.4 $0.68
9/30/202315,800 shares $10,892.52 +79.6%0.3%0.2 $0.69
9/15/20238,800 shares $6,688.00 +27.5%0.1%0.1 $0.76
The Prophet's Newest Prediction (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
8/31/20236,900 shares $4,637.49 -11.5%0.1%0.1 $0.67
8/15/20237,800 shares $5,588.70 +14.7%0.1%0.1 $0.72
7/31/20236,800 shares $5,576.68 -26.9%0.1%0 $0.82
7/15/20239,300 shares $7,786.89 -35.9%0.2%0 $0.84
6/30/202314,500 shares $13,735.85 -74.6%0.3%0 $0.95
6/15/202357,000 shares $63,270.00 -39.8%1.0%0.1 $1.11
5/31/202394,700 shares $99,435.00 +38.5%1.6%0.1 $1.05
5/15/202368,400 shares $77,292.00 -26.8%1.2%0.1 $1.13
4/30/202393,400 shares $100,872.00 -44.9%2.2%0.1 $1.08

REVB Short Interest - Frequently Asked Questions

What is Revelation Biosciences' current short interest?

Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 69,600 shares of REVB short. 7.22% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest.

What is a good short interest ratio for Revelation Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REVB shares currently have a short interest ratio of 1.0. Learn More on Revelation Biosciences's short interest ratio.

What is a good short interest percentage for Revelation Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.22% of Revelation Biosciences' floating shares are currently sold short.

Is Revelation Biosciences' short interest increasing or decreasing?

Revelation Biosciences saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 69,600 shares, a drop of 41.3% from the previous total of 118,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Revelation Biosciences' float size?

Revelation Biosciences currently has issued a total of 905,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 963,500 shares.

How does Revelation Biosciences' short interest compare to its competitors?

7.22% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revelation Biosciences: Minerva Neurosciences, Inc. (0.50%), BriaCell Therapeutics Corp. (5.22%), Cellectar Biosciences, Inc. (3.44%), Affimed (4.46%), Lakeshore Biopharma Co., Ltd. (0.05%), Talphera, Inc. (0.89%), Athira Pharma, Inc. (2.54%), Cyclerion Therapeutics, Inc. (2.69%), BioLineRx Ltd. (5.37%), Kiora Pharmaceuticals, Inc. (1.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Revelation Biosciences stock?

Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Revelation Biosciences?

A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further.

How often is Revelation Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:REVB) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners